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ABSTRACT Self-assembled DNA delivery systems based on cationic lipids are simple to produce and weakly hazardous in
comparison with viral vectors, but possess a signiﬁcant toxicity at high doses. Phospholipids are in contrast intrinsically safe; yet
their association with DNA is problematic because of unfavorable electrostatic interactions. We achieve the phospholipid-DNA
complexation through the like-charge attraction induced by cations. Monovalent cations are inappropriate due to their poor
binding afﬁnity with lipids as inferred from electrophoretic mobility, whereas x-ray diffractions reveal that with multivalent cations,
DNA is complexed within an inverted hexagonal liquid-crystalline phase. Coarse-grained Monte Carlo simulations conﬁrm the
self-assembly of a DNA rod wrapped into a lipid layer with cations in between acting as molecular glue. Transfection exper-
iments performed with Ca21 and La31 demonstrate efﬁciencies surpassing those obtained with optimized cationic DOTAP-
based systems, while preserving the viability of cells. Inspired by bacteriophages that resort to polycations to compact their
genetic materials, complexes assembled with tetravalent spermine achieve unprecedented transfection efﬁciencies for phos-
pholipids. Inﬂuence of complex growth time, lipid/DNA mass ratio, and ion concentration are examined. These complexes may
initiate new developments for nontoxic gene delivery and fundamental studies of biological self-assembly.
INTRODUCTION
Gene therapy suffers from a lack of efﬁcient and nontoxic
delivery systems (1). DNA is traditionally delivered by either
viral or nonviral vector-mediated systems (2). Viral methods
are by far the most efﬁcient in terms of delivery and ex-
pression, owing to the highly evolved and specialized com-
ponents of natural viruses (3,4). They present, however, a
number of restrictions due to the induced toxicity and immu-
nogenicity, the limited size of DNA that can be carried, the
lack of speciﬁcity, and the high cost of production (5). Con-
siderably easier to prepare and safer to use, artiﬁcial viruses
are made of self-assembling complexes of DNA with pos-
itively charged molecules such as lipids, polymers, peptides,
or combinations thereof; yet twomajor difﬁculties have limited
their success so far in clinical applications (5–8): i), low
transfection efﬁciencies (TE) in comparison with that of their
viral counterpart, and ii), problems of carrier toxicity, elim-
ination, and biodegradability, especially occurring at high in-
jected doses when increasing the total amount of delivered
DNA.
A particular emphasis has been given to lipids because
they are the main constituents of cell and organelle mem-
branes for all living organisms; accordingly, numerous cat-
ionic lipids have been synthesized to date for the delivery of
nucleic acids into cultured cells (9–11), as well as in clinical
trials (12–14). Despite a few successful and promising at-
tempts in vivo, the toxicity arising from these synthetic
materials has been hampering their use in the pharmaceutical
industry. Strong administered doses and high lipid charges
are generally more toxic to a variety of cell types including
cancer cell lines. Cell shrinking, inﬂammatory reactions, and
immunotoxicity are among the many harmful effects asso-
ciated with cationic lipids (15).
Unlike positively charged lipids that are only found in
extremely small amounts in certain tissues (16), phospho-
lipids, either anionic or zwitterionic, are ubiquitous in cell
membranes and may thereby constitute better candidates for
lipid-based delivery systems. The challenge is to achieve the
complexation between nucleic acids and phospholipids, given
their low afﬁnity arising from unfavorable electrostatic in-
teractions. Several x-ray diffraction studies have revealed
ordered phases in which DNA was complexed within liquid-
crystalline structures of phospholipids through the mediation
of divalent cations (17–20). Interestingly, the geometry of
these complexes was identical to that observed with cationic
lipids, that is, lamellar and inverted hexagonal structures
(21). These ﬁndings support the capability of phospholipids
to compact nucleic acids under certain conditions. Very
recently, phosphatidylcholine lipids could transfer plasmid
DNA into mouse ﬁbroblasts in the presence of bivalent metal
cations. Unfortunately, the transfection efﬁciency achieved
was too low for practical applications (22).
In this work, we report highly efﬁcient phospholipid-DNA
complexes assembled by using multivalent cations including
trivalent and tetravalent cations. We also attempt to shed
light on the mechanisms underlying the self-assembly pro-
cess, as well as to identify the key parameters necessary to
achieve high delivery performances. We ﬁrst investigate the
binding properties of multivalent cations with phospholipid
membranes and correlate them with the complexation of
DNA. X-ray diffractions and Monte Carlo simulations enable
us to get some insight into the assembly of complexes at a
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molecular level. We next monitor the transfection efﬁcien-
cies of complexes made of various phospholipids and mul-
tivalent cations, and compare them to a cationic mixture of
lipids. The cytotoxicity on cultured cells is also assessed.
Then, we seek the factors affecting the formation of com-
plexes, and analyze their inﬂuence on the transfection perfor-
mances. We ﬁnish with a summary on the supramolecular
structure of complexes, the key parameters for gene delivery,
and on further possible improvements.
Self-assembly of phospholipid-DNA complexes
Ion adsorption at the surface of biological membranes con-
tributes to many cellular processes such as cell adhesion, ion
transport, or binding of ligands. Previous studies, involving
techniques such as electrophoretic mobility, NMR, titration
calorimetry, and molecular dynamics simulations, reported a
good afﬁnity between phospholipid membranes and multiva-
lent cations (23–25). Table 1 summarizes the binding properties
of some inorganic cations with 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE). The binding constant Kmea-
sures how strong the afﬁnity of ions with the lipid membrane
is, whereas the density of binding sites N represents the
maximum number of ions that can be adsorbed per unit area.
These values were obtained by ﬁtting the ion concentration
dependence of membrane surface potentials deduced from
electrophoresis data, to the Gouy-Chapman-Stern (GCS) theory
(25). Note that as the valence and the size of ions increase,
the GCS theory deviates from the experiment, and in partic-
ular, we could not estimate accurately the binding parameters
of large polycations such as spermine on phospholipid mem-
branes. A direct consequence of cation binding is the in-
crease of the membrane charge density—calculated from
electrophoresis data through the Grahame equation—with
ion concentration, as illustrated on Fig. 1 A. At physiological
pH, DOPE had a slightly negative intrinsic membrane charge
density s0 ¼ 0:0157 e:nm2: Due to a low density of
binding sites, K1 did not alter the charge density of DOPE
even at high concentrations, whereas Ca21 and La31 could
make it strongly positive. Thanks to a 100-fold larger K, the
charge density increased much more rapidly upon the
addition of La31 than with Ca21. Moreover, we can see
that the binding model behind the GCS theory accounts well
for the concentration dependence of the charge density and
this agreement supports the accuracy of the values listed in
Table 1.
Because multivalent cations bind to lipid membranes and
reverse their charge density, DNA can be complexed into a
liquid-crystalline structure determined by small angle x-ray
scattering. Fig. 1 B shows x-ray patterns measured on mix-
tures of DOPE, DNA, and cations. Upon the use of 200 mM
of monovalent K1, the sample did not precipitate and no
ordered structure was visible within the detection range of
our instrument, suggesting that DNA complexation did not
occur consistently with the poor binding properties of K1. In
contrast, the complexation of DOPE-DNA by 200 mM of
Ca21 and La31 gave rise clearly to the coexistence of two
hexagonal phases: one denoted HII and corresponding to a
phase of pure DOPE (26), and a second one labeled HCII and
referring to a phase where DNA strands are surrounded by
a lipid monolayer and arranged on a hexagonal lattice (17,
21,27). In the case of Ca21, the unit cell sizes could be in-
ferred from the positions of Bragg peaks as aHII ¼ 78 A˚ and
aHCII ¼ 69 A˚; this latter spacing corresponding well to the
thickness of one DOPE membrane bilayer (;45 A˚) plus the
diameter of one DNA chain (;20 A˚) and two layers of;2 A˚
each to accommodate the bridging cations. We found for
La31, aHII ¼ 77 A˚ and aHCII ¼ 67 A˚; which are close to the
values obtained for Ca21. Furthermore, there are some evi-
dences that the complexed lipids were in liquid state: ﬁrst,
DOPE has a gel-to-liquid phase transition temperature of
16C, and it was reported by other groups that the com-
plexation with DNA and cations increases the transition tem-
perature by no more than 10C (28). Also, our differential
scanning calorimetry measurements from 0C to 60C
TABLE 1 Intrinsic binding constants (K) and density of binding
sites (N ) describing the adsorption of inorganic cations to
zwitterionic DOPE membranes
Ion K (M1) N (nm2)
K1 ;0 ,0.02
Mg21 4.4 6 1.4 0.29 6 0.09
Ca21 4.0 6 1.1 0.63 6 0.15
La31 450 6 30 0.32 6 0.01
These parameters were inferred from electrophoresis data ﬁtted with the
GCS theory.
FIGURE 1 Ion binding and self-assembly structure for zwitterionic
phospholipid-DNA complexes. (A) surface charge density of DOPE mem-
brane as a function of the ion concentration in solution for three cations of
different valence: La31 (d), Ca21 (n), and K1 (:). The values were
calculated from experimental electrophoresis data with the Grahame eq-
uation. The solid line represents the prediction from the Gouy-Chapman-
Stern (GCS) theory by using the parameters given in Table 1. (B) Small angle
x-ray scattering patterns of DOPE-DNA complexes at ion concentrations
of 200 mM and L/D ¼ 7. The integers in parentheses are Miller indices.
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revealed no phase transition, indicating the complexed lipid
chains were already melted.
Although x-ray diffractions experiments give valuable in-
formation on liquid-crystalline structures, we cannot be sure
about the detailed assembly. To support the above results, we
carried out Monte Carlo simulations with a simple coarse-
grained water-free model of lipids, which was reportedly
proven to yield a self-assembly of membrane bilayer (29).
The model was only modiﬁed to set a low bending modulus
to membranes, so as to get mechanical properties close to
those of DOPE. At the initial state of simulations, zwitter-
ionic lipids and divalent cations were distributed randomly
around a negatively charged DNA rod (Fig. 2 A). After the
equilibrium was reached (Fig. 2 B), the cations coated the
DNA uniformly, and the assembly was wrapped up in a lipid
bilayer, consistently with the structure suggested by x-ray
experiments. In absence of cations, no stable conﬁguration
could be obtained as the repulsion between DNA and the
negative part of zwitterionic lipid heads prevents their asso-
ciation. With cations, the repulsive electrostatic forces are
screened—or even become attractive—and short-range inter-
actions ensure stable binding. It should be noted here that
since only one DNA rod was introduced in the simulations,
the lipids formed a bilayer to protect the exposed hydro-
phobic tails from the bulk aqueous environment. In reality, in
presence of several DNA molecules, only one lipid mono-
layer should coat each DNA.
Gene transfection and toxicity
We assessed the transfection capabilities of phospholipid-
DNA complexes on two different human tumor cell lines, one
from glioblastoma (U87), the other from hepatoma (HepG2).
For the sake of clarity and to rule out a possible bias intro-
duced by the physiological state of cells, the transfection ef-
ﬁciencies, quantiﬁed by luminescence assay, were normalized
to the values obtained under the same experimental conditions
with a binary mixture of 1,2-dioleoyl-3-trimethylammonium-
propane (DOTAP) and DOPE at a ratio of 60:40%. This lipid
mixture is a commonly used cationic lipid transfectant and
good performances have been reported in the literature (30).
Fig. 3, A–B, shows the relative transfection efﬁciencies for
DOPE-DNA complexes. The lipid/DNA mass ratio (L/D)
and the growth time of complexes before transfection (tg)
were both maintained at 7 and 2 h, respectively. By using
Ca21, we successfully transfected U87 and HepG2 cell lines,
and the level of luciferase activity was comparable to that
achieved with cationic DOTAP/DOPE for ion concentra-
tions of 200 mM and 50 mM, respectively (Fig. 3 A). In the
absence of lipids, the relative TE did not go beyond ;0.03
for U87 and ;0.08 for HepG2. Fig. 3 B depicts the
performances obtained on U87 with DOPE-DNA complexed
by cations of different valences. As expected, lipids mixed
with K1 failed because DNA was not even complexed. With
multivalent cations, the efﬁciencies increased in the follow-
ing order: Mg21 , Ca21 , La31, [La31] ¼ 100 mM giving
the best level at ;2.6-fold higher than cationic DOTAP/
DOPE. It is worth noting that the efﬁciency curve for La31 is
shifted toward lower ion concentrations by three orders of
magnitude with respect to that of Ca21, which is ascribed to
the much higher binding constant of the trivalent cations.
The presence of a peak in the transfection efﬁciency curve
is attributed to the interactions between lipid membrane and
DNA: at low cation concentrations, only a few DNA mol-
ecules are complexed, and the total number of delivered
DNA is therefore low. At high ion concentrations, DNA
molecules are believed to be strongly bound to lipids and
cannot be released properly in the endosome toward the
cell nucleus. The optimal ion concentration is cell dependent
(Fig. 3 A), and this can be seen as a valuable advantage for in
vivo cell targeting, ensuring that one cell line is efﬁciently
transfected whereas the others remain unaffected.
We monitored the toxicity induced by the complexes by
performing proliferation assays on the transfected cells. To
keep levels of transfection optimal, we varied the amount of
delivered DNA while maintaining the L/D ratio constant. We
retained the combination of DOPE with 100 mM of La31,
and the corresponding proliferation data of transfected U87
and HepG2 cell lines are shown on Fig. 3 C. With 0.2 mg of
DNA considered as a nominal value, the graph shows that
even with 10-fold more DNA to transfect, 89% and 79% of
U87 and HepG2 cells, respectively, were still viable af-
ter 48 h of culture. Other assays involving 200 mM of Ca21
for the preparation of complexes resulted in lower viabilities,
emphasizing the importance of ion concentration to the tox-
icity. In a pharmaceutical context, the use of cations having
a high afﬁnity with lipids and DNA such as La31 is beneﬁ-
cial for reduced toxicity, because it allows the preparation of
phospholipid-DNA complexes with small amounts of cat-
ions (several orders of magnitude between Ca21 and La31).
Thus, the intracellular ionic environment is less affected and
the cell viability is preserved.
Phospholipid-DNA complexation is not limited to inor-
ganic ions. Tetravalent polycation spermine (spr41) is found
FIGURE 2 Monte Carlo simulations of the self-assembly of zwitterionic
lipids (hydrophilic part in dark gray and hydrophobic one in light gray) and
DNA (central disk) with divalent cations (small light gray spheres).
(A) Initial and (B) equilibrium conﬁgurations.
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in a wide variety of organisms and tissues, and is in particular
exploited by bacteriophage T4 and herpes simplex virion as a
compacting agent to accommodate DNA in their tiny viral
capsid (31,32). In vitro, spermine is also known to precipitate
pure DNA or in a mononucleosome core particle state (33–
35). We assembled phospholipid-DNA complexes that are
inspired by these above-mentioned natural viruses, by sub-
stituting inorganic cations with spermine. We found quali-
tatively from electrophoresis data that the binding properties
of spermine were not satisfactory with DOPE, but were good
enough to reverse the membrane charge density of anionic
phospholipids such as 1,2-dioleoyl-sn-glycero-3-phosphate
(DOPA). Fig. 4 A shows the very high efﬁciency exhib-
ited by the combination DOPA-spr41 on U87 cells: an;18-
fold higher expression of luciferase than that achieved
with cationic DOTAP/DOPE, for just 500 mM of spermine.
This outcome was conﬁrmed under ﬂuorescence micro-
scope by expressing green ﬂuorescent protein instead of
luciferase in cells (Fig. 4 B). Even in the presence of serum
and transfecting directly in supplemented culture medium,
the luminescence assay yielded better readings because the
complexes were in contact with cells for longer durations
(data not shown). In absence of DOPA or cations, the level of
transfection was negligible. Note that the optimal experi-
mental conditions, namely the lipid/DNA mass ratio and the
growth time before transfection, differed from the case with
DOPE.
Factors affecting the delivery
The factors conditioning the delivery are exempliﬁed with
natural phospholipids extracted from egg yolk, on U87 cell
line: they were egg phosphatidylethanolamine (egg PE), egg
FIGURE 3 Relative transfection efﬁciencies
of DOPE (A) with Ca21 on U87 (red line) and
HepG2 (blue line) cells, and (B) on U87 cells
with different cations: La31 (n), Ca21 (d),
Mg21 (:), and K1 (;). Inset is a close-up view
at ion concentrations comprised between 100
and 400 mM. In all experiments, L/D ¼ 7 and
tg ¼ 2 h: (C) Cell proliferation assays for vary-
ing amounts of DNA to transfect. Complexes
are made of DOPE and ½La31 ¼ 100mM: The
tested cell lines are U87 and HepG2, the
incubation time 48 h, and the lipid/DNA mass
ratio maintained at L/D ¼ 7.
FIGURE 4 Transfection of U87 with DOPA and spermine (spr41).
(A) Relative transfection efﬁciency as a function of spermine concentration.
Inset is the efﬁciency obtained in absence of lipids. L/D ¼ 20 and tg ¼ 4 h:
(B) Fluorescence image of U87 cells transfected with plasmid DNA
encoding GFP, by DOTAP/DOPE (top) and DOPA=½spr41 ¼ 300mM;
L/D ¼ 20, tg ¼ 4 h (bottom), after 3 days of culture.
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phosphatidylcholine (egg PC), and egg phosphatidic acid
(egg PA). Egg PE achieved a good relative TE of ;2.2 at
½Ca21 ¼ 40mM as shown by Fig. 5 A. In contrast, egg PC,
yet also a mixture of zwitterionic lipids, did not exceed 0.09,
which is barely better than in absence of lipids. At an inter-
mediary level, anionic egg PA stood with a relative TE
approaching 0.25. These results suggest that the biophysical
properties of lipids, especially the membrane bending mod-
ulus that was much higher for PC ( 10 kT, k the Boltzmann
constant and T the temperature) than for PE ( kT) mem-
brane, and the intrinsic charge density play a critical role in
the delivery process. Similar conclusions were drawn from ex-
periments on cationic lipids (9,30).
Like cationic lipid systems (36), the size of complexes
before transfection was found to be determinant as depicted
on Fig. 5 B. Size and transfection efﬁciency were strongly
correlated through the growth time before transfection tg.
Naked egg PE particles had a size distribution centered at
;96 nm. Within the ﬁrst seconds after complex formation,
the size jumped to 300 nm and reached ;425 nm after
15 min. The transfection efﬁciency was the best when com-
plexes were administered to cells at this very moment. It is
worth noting that the optimal growth time could vary stron-
gly from one lipid-ion combination to another, ranging from
15 min for egg PE-Ca21 to 4 h for DOPA-spr41. As egg
PE-DNA complexes continued to self-assemble, their size
increased to ;650 nm after 4 h. In terms of transfection, the
latter were 10-fold less efﬁcient than their 425-nm counter-
parts. This is easily understandable as small complexes do
not carry enough DNA to transfect and large complexes are
too big to be assimilated into cells by endocytosis and/or
cell-complex fusion.
Fig. 5 C gives the dependencies of the lipid/DNA mass
ratio and the ion concentration for egg PE/Ca21. The trans-
fection efﬁciency peaked at L/D ¼ 10 and ½Ca21 ¼ 40mM;
and besides this, the efﬁciency dropped steeply yielding low
values. Both parameters set the overall charge of phospholipid-
DNA complexes: if too low, the uptake to cells is inefﬁcient;
if too high, the complexes are trapped inside the endosome
and DNA cannot migrate to the nucleus. In principle, L/D,
the ion concentration, and tg should all be adjusted simul-
taneously to achieve optimal delivery to a given cell line.
This may appear troublesome when one wants to transfect a
large variety of cells. However, gene therapy requires only
well-speciﬁed cells to be transfected and the delivery into
nontargeted cells can lead to a fatal outcome. The narrow




Lipids purchased from Avanti Polar Lipids (Alabaster, AL) and dissolved in
chloroform:methanol 2:1 (v/v) were dried by rotary evaporation under
FIGURE 5 Gene transfections with natural phospholipids and Ca21 ions.
(A) Relative transfection efﬁciency with varying concentrations of Ca21 on
U87 cells: egg PE (black n), egg PA (gray d), egg PC (e). L/D ¼ 7 and
tg ¼ 15min: (B) Transfection efﬁciency of egg PE in relative light units per
mg of proteins versus growth time of lipoplexes before transfection tg (bars,
left axis), and their corresponding size (¤, right axis). L/D ¼ 7 and
½Ca21 ¼ 75mM: (C) Relative transfection efﬁciency of egg PE as a
function of both L/D and ½Ca21 at ﬁxed tg ¼ 15min:
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vacuum at 42C. They were placed afterwards in a vacuum chamber over-
night so as to remove the last traces of organic solvent. Millipore (Billerica,
MA) sterilized water was added to form liposomes in solution at 0.5 mg/mL
for transfection, and 5 mg/mL for x-ray diffraction. After overnight incu-
bation at room temperature, the liposomes were tip sonicated for 10 min, and
extruded through a 0.2-mm polycarbonate ﬁlter. Lipids and DNA ﬁrst, then
cations in chloride form (KCl, CaCl2. . .) were mixed together in desired
ratios and incubated at room temperature during a period tg (growth time)
before transfection. For x-ray experiments, l-DNA (Roche Applied Science,
Singapore) was precipitated and mixed thoroughly with concentrated lipids
by gentle stirring; after addition of ions, the complexes were allowed to form
for several days at 4C. The liposomal transfectant of reference was prepared
from a binary mixture of 60% DOTAP and 40% DOPE in mol. DNA was
complexed in Millipore sterilized water at a DOTAP-to-DNA charge ratio of
3, and the growth time before transfection was limited to 30 min. These
conditions were reportedly optimal for gene delivery (30). The size of com-
plexes was determined by dynamic light scattering using a ZetaSizer Nano
system from Malvern Instruments (Malvern, UK).
Ion binding assessment
Liposomes with no DNA were prepared as described above in buffer
solution of 2 mM Tris pH 7.0, and ions were added up to the desired con-
centration. After overnight equilibration, z-potentials were measured with a
ZetaPALS system from Brookhaven Instruments (Holtsville, NY). The sur-
face potentials were obtained by solving numerically the Poisson-Boltzmann
equation, considering a thickness of shearing layer of 1 A˚. The binding con-
stants K and the densities of binding sites N were inferred from least-square
minimization between the Gouy-Chapman-Stern theory and the computed
surface potentials (25). The charge densities shown on Fig. 1 A were cal-











where s is the charge density, e and e0 the dielectric constant and the
permittivity of free space, respectively, k the Boltzmann constant, T the tem-
perature, ni(N) the bulk ion concentrations, zi the ion valences, e the ele-
mentary charge, and cs the surface potential of liposomes. The sum is
performed over all ions in solution.
X-ray diffraction
The small angle x-ray scattering setup comprised the SAXSess small angle x-ray
scattering instrument from Anton Paar GmbH (Graz, Austria) and the PW3830
laboratory x-ray generator (40 kV, 50 mA) with a long-ﬁne focus sealed x-ray
tube (CuKa wavelength of l ¼ 0:1542 nm) from PANalytical (Almelo, The
Netherlands). Detection was performed with the two-dimensional imaging-
plate reader Cyclone by Perkin Elmer (Wellesley, MA). The sample was
sandwiched in a Kapton cell and measurements were performed in the slit
conﬁguration with a solid sample holder for 20 min. The data were collected
up to a q-value of 4 nm1, where q ¼ ð4p=lÞsinðu=2Þ is the length of the
scattering vector and u is the scattering angle, i.e., the angle of observation.
Data was corrected from instrumental broadening effects (‘‘slit-smearing’’)
with the GIFT software and ﬁtted with a sum of Lorentzian functions.
Differential scanning calorimetry was performed with a Q 100 calorimeter
(TA Instruments, New Castle, DE) for temperatures ramped up from 0C
to 60C at a rate of 3C/min.
Monte Carlo simulations
The model used was based on a coarse-grained water-free membrane model,
which has been proven to produce self-assembled lipid bilayers (29,37). The
lipids consisted of one hydrophilic and two hydrophobic spherical particles
with short-range pair interactions between them. Their diameter was set to
6.3 A˚ and the Lennard-Jones pair potentials taken as in Farago (29) except
for e13 ¼ 2 kT and e23 ¼ 3:75 kT so as to lower the bending modulus of lipid
membrane. The hydrophilic spheres carried one dipole (moment 5 e.A˚) ori-
ented along the molecule to account for the zwitterionic charge of lipids. The
cations were modeled as charged spheres of 2 A˚ in diameter interacting with
other cations and lipids through a purely repulsive 12th-order Lennard-Jones
potential, plus the Coulomb potential. An inﬁnitely long rigid rod with a
uniform axial charge lDNA ¼ 0:59 e:A˚1 and a diameter DDNA ¼ 20 A˚
was employed for DNA. It interacted with all other particles through the
following pair potential,








where Dparticle and zparticle stand for the diameter and the valence of the
particle in consideration, and r the distance particle-DNA. Monte Carlo
simulations were used to generate the temporal evolution of the lipids, while
the position of the rod was ﬁxed. Each Monte Carlo step consisted of an
attempt to translate the particles and rotate the lipids around their midatom.
The size of the simulation box was 80 A˚ and 171 lipids were simulated.
Cell transfection
Human glioblastoma U87 and human hepatoma HepG2 were cultured at
37C in supplemented cell medium (Dulbecco’s modiﬁed eagle’s medium
(DMEM) with 10% fetal bovine serum, penicillin-streptomycin, and
L-glutamine) in a humidiﬁed atmosphere containing 5% CO2. The day
before transfection, cells were seeded in 48-well plates so that they were 70
; 80% conﬂuent at the time of transfection. For each well, 200 ng of
plasmid DNA encoding for a modiﬁed ﬁreﬂy luciferase (Photinus Pyralis)
under the control of a strong viral promoter (SV40) (pGL3 promoter,
Promega, Madison,WI) was used. Fig. 4 B involved 200 ng of plasmid DNA
encoding green ﬂuorescent protein. The cells were incubated for 4 h with
250 mL of OptiMEM reduced serum medium (Invitrogen, Carlsbad, CA)
and 50 mL of phospholipid-DNA complexes, then with supplemented
cell medium for an additional 24 h. Gene expression was measured with the
Luciferase Assay System from Promega, and luminescence quantiﬁed by a
Berthold Lumat LB 9507 luminometer (Bad Wildbad, Germany). The light
output readings, in relative light units (RLU), were normalized to the weight
of total cellular protein determined using Bio-Rad protein assay dye reagent
(Bio-Rad, Hercules, CA). The relative transfection efﬁciency was obtained
by further normalizing to the transfection efﬁciency of cationic DOTAP/
DOPE under the same experimental conditions. All experiments were per-
formed in triplicate.
Cytotoxicity
The cells of interest were seeded in 96-well plates, 1 day before transfection.
Phospholipid-DNA complex solution (20 mL) containing 80 ng of plasmid
DNAwas added to each well ﬁlled with 100 mL of OptiMEM, and incubated
for 4 h. The wells were subsequently reﬁlled with supplemented medium and
the plate stored for 48 h in the incubator. Cell proliferation was evaluated
using the CellTiter 96 assay from Promega with 3 h of incubation, and the
quantity of living cells in culture was determined by absorbance at 490 nm.
CONCLUDING REMARKS
In spite of unfavorable electrostatic interactions, phospholipids
and DNA can be assembled into an ordered liquid-crystalline
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structure upon the mediation of multivalent cations. The
process takes advantage of the like-charge attraction arising
from the counterions that screen repulsive electrostatic forces
between lipids and DNA, and allow short-ranged attractive
forces to come into play (38). The underlying physics,
involving electrodynamic theories, is still far from being un-
derstood, and phospholipid-DNA complexes may constitute
a valuable platform for fundamental studies on biological
self-assembly.
The internal structure of complexes consists of cylindrical
DNA strands coated by lipid monolayers with ions in be-
tween, and arranged on a two-dimensional hexagonal lattice
(HCII phase) as depicted by Fig. 6. Upon mixing of the com-
ponents, the complexes spontaneously grow in size until
equilibration.
The efﬁcacy in gene delivery with phospholipid-DNA
complexes relies on critical factors:
The growth time before transfection tg sets the size of
complexes when administered to cells, and conditions
the complex uptake.
The ion concentration and the lipid/DNA mass ratio L/D
set the overall charge of complexes, which is connected
to the complex uptake and to the DNA release from
endosome.
The concentration and valence of ions control the like-
charge attraction and therefore the DNA complexation.
The lipids themselves take part in the complex uptake and
the induced toxicity.
Comprehensive literature already exists on lipid research
unlike other chemical reagents such as dendrimers and pro-
phyrin derivatives, for which a great deal of work remains to
be done before these are used clinically. Elaborate strategies
originally developed for liposomal drug and gene delivery
are readily applicable to phospholipid-DNA complexes: spe-
ciﬁc cell targeting by antibody conjugation (39,40) or col-
loidal stabilization by polymer grafting (41) are among the
numerous techniques devoted to lipids to achieve artiﬁcial
delivery systems with virus-like functions.
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